<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01530958</url>
  </required_header>
  <id_info>
    <org_study_id>11-07399</org_study_id>
    <secondary_id>1R34DK093992-01</secondary_id>
    <nct_id>NCT01530958</nct_id>
  </id_info>
  <brief_title>Kidney Awareness Registry and Education</brief_title>
  <acronym>KARE</acronym>
  <official_title>The Kidney Awareness Registry and Education Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the feasibility and acceptability of two different&#xD;
      interventions aimed at improving health outcomes among patients with chronic kidney disease&#xD;
      (CKD), who are at high risk of CKD progression. Specifically, this study will examine how&#xD;
      best to implement a provider-level intervention (access to a CKD-registry) and a&#xD;
      patient-oriented intervention (automated telephone self-management (ATSM) + health coach) on&#xD;
      patient health outcomes, with a 2x2 factorial design.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood pressure measurement at baseline and at one year follow-up</measure>
    <time_frame>Baseline and one year follow-up</time_frame>
    <description>Blood pressure will be measured at baseline and also at the follow-up visit at one year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in CKD awareness, functional status, and symptoms at baseline and at one year follow-up</measure>
    <time_frame>Baseline and one year follow-up</time_frame>
    <description>CKD awareness, functional status, and symptoms will be measured at baseline and also at the follow-up visit at one year. Assessments will be made by standardized phone calls throughout the study.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">375</enrollment>
  <condition>Chronic Kidney Disease (CKD)</condition>
  <arm_group>
    <arm_group_label>ATSM + Health Coach and CKD Registry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CKD Registry</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ATSM + Health Coach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care (no interventions)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CKD Registry</intervention_name>
    <description>Primary care providers (PCPs) will have access to a Chronic Kidney Disease (CKD) registry for patient care. The registry will:&#xD;
identify patients with CKD&#xD;
notify PCPs of a patients' CKD status&#xD;
provide PCP outreach with NKDEP guidelines and patient educational materials</description>
    <arm_group_label>ATSM + Health Coach and CKD Registry</arm_group_label>
    <arm_group_label>CKD Registry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ATSM + Health Coach</intervention_name>
    <description>Patients with CKD will participate in an Automated Telephone Self Management (ATSM) program, which blends automated phone calls with live targeted call-backs from a health coach. Patients will receive bi-weekly automated calls for 52 weeks in their native language, consisting of pre-recorded queries pertaining to CKD management, preventive services, and lifestyle changes. Patients will interact with the system using a touch-tone keypad; Out-of-range values or invalid responses will prompt a live call-back within 24-48 hours by a health coach.</description>
    <arm_group_label>ATSM + Health Coach</arm_group_label>
    <arm_group_label>ATSM + Health Coach and CKD Registry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Primary care providers will manage their patients with CKD per usual care.&#xD;
Patients will receive usual care.</description>
    <arm_group_label>Usual Care (no interventions)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with CKD (defined as estimated Glomerular Filtration Rate &lt; 60ml/min/1.73m2&#xD;
             or proteinuria consistently over 3 months) who speak English, Spanish or Cantonese and&#xD;
             have a primary care provider&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Kidney transplant recipients; pregnant women; individuals with an eGFR &lt;15 ml/min/1.73&#xD;
             m2; prevalent dementia; impaired cognition or severe mental illness; expected life&#xD;
             expectancy &lt;6 months; no phone access; self-reported hearing impairment; severe visual&#xD;
             impairment preventing use of a touch-tone telephone keypad; and non-study language&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil Powe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Francisco Department of Public Health</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>February 7, 2012</study_first_submitted>
  <study_first_submitted_qc>February 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2012</study_first_posted>
  <last_update_submitted>January 19, 2021</last_update_submitted>
  <last_update_submitted_qc>January 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CKD</keyword>
  <keyword>Automated Telephone Self Management</keyword>
  <keyword>Registry</keyword>
  <keyword>CKD awareness</keyword>
  <keyword>Self efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data may be available upon contact of study PI.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

